Alpha Cognition Inc. (ACOG)
ACOG trades on Nasdaq. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$8.80
-0.45% on the day
Market cap
$191.6M
Micro cap
Revenue · 2025
$10.2M
No prior year to compare
Net income · 2025
-$20.7M
-202.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ACOG on Nasdaq |
| Sector | The Nasdaq screener gives no sector |
| Industry | The Nasdaq screener gives no industry |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001655923 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | A1 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $10.2M |
| Net income | -$20.7M |
| Operating income | -$22.7M |
| Net margin | -202.2% |
| Operating margin | -221.7% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $66.0M |
| Total assets | $79.7M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 18.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2025-10-01 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-31 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-13 |
| Latest current report CURRENT REPORT | 8-K | 2026-06-23 |
| Latest proxy DEFINITIVE ADDITIONAL MATERIALS | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 214 recent filings. All filings on EDGAR.
Peers
No industry from the screener, so peers can't be matched.
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier